Andrew Spokes portfolio, Q1 2026
Farallon Capital Management · 13F for the quarter ending Mar 31, 2026
For Q1 2026, Farallon Capital Management reported $18.3B across 172 US-listed positions, led by Electronic Arts Inc (8.3%), RVMD (7.2%) and AMZN (4.8%). Compared with its filing for Q4 2025, Andrew Spokes opened 48 new positions, added to 31, reduced 30 and sold out of 26; 63 positions did not change.
The largest purchase was an addition to Electronic Arts Inc ($496.4M); the largest sale, the sale of the whole position in Exact Sciences Corp ($650.5M).
Key facts
- 13F portfolio value
- $18.3BQ1 2026
- Positions
- 172
- Largest holding
- Electronic Arts Inc 8.3%
- New positions
- 48
- Sold out
- 26
- Filed
- May 15, 2026
Holdings as of (Q1 2026), filed with the SEC on and amended on . Changes are measured against the filing for Dec 31, 2025. Every tracked investor's Q1 2026 13F.
The filing it is compared with has a cover page that disagrees with its own table, so the changes shown may be off.
Bought and sold in Q1 2026
| Stock | Move | Shares | Size | Of portfolio |
|---|---|---|---|---|
Exact Sciences Corpno ticker on file | ▼ Sold out | −6.41M | $650.5M | 3.56% |
Electronic Arts Incno ticker on file | ▲ Added 48% | +2.44M | $496.4M | 2.72% |
CyberArk Software Ltdno ticker on file | ▼ Sold out | −1.05M | $469.7M | 2.57% |
Warner Bros Discovery Incno ticker on file | ▲ Added 141% | +16.32M | $448.1M | 2.45% |
| Salesforce IncCRM | ▼ Sold out | −1.26M | $334.1M | 1.83% |
| Nasdaq IncNDAQ | ▼ Sold out | −2.99M | $290.3M | 1.59% |
| Broadcom IncAVGO | ▲ Added 99% | +887.1K | $274.6M | 1.50% |
| Roivant Sciences LtdROIV | ▲ Added more than 10× | +9.64M | $267M | 1.46% |
| KKR & Co. IncKKR | ▲ Added 132% | +2.65M | $245.5M | 1.34% |
Avidity Biosciences Incno ticker on file | ▼ Sold out | −3.23M | $233.2M | 1.28% |
| New York Times Co MTN BeNYT | ▼ Sold out | −3.28M | $227.7M | 1.25% |
| WabtecWAB | ▼ Reduced 35% | −866.6K | $216.6M | 1.19% |
Dayforce Incno ticker on file | ▼ Sold out | −2.93M | $202.3M | 1.11% |
| The Walt Disney CoDIS | ▼ Reduced 42% | −1.72M | $166.2M | 0.91% |
| CBRE Group IncCBRE | ▼ Sold out | −983.77K | $158.2M | 0.87% |
| Natera IncNTRA | ▼ Reduced 18% | −707K | $141.4M | 0.77% |
| Mastercard IncMA | ▲ Added 152% | +262.4K | $131.1M | 0.72% |
| AramarkARMK | ▼ Reduced 34% | −3.22M | $130.6M | 0.72% |
| Bitwise 10 Crypto Index ETFBITW | ▼ Reduced 82% | −2.78M | $124.1M | 0.68% |
| Thermo Fisher Scientific IncTMO | ▲ Added 39% | +245.8K | $120.8M | 0.66% |
| Exelixis IncEXEL | ▼ Reduced 17% | −2.6M | $111.4M | 0.61% |
| iShares Bitcoin Trust ETFIBIT | ▼ Sold out | −2.14M | $106.1M | 0.58% |
| Revolution Medicines IncRVMD | ▼ Reduced 6.7% | −978K | $95.1M | 0.52% |
| Synopsys IncSNPS | ▲ Added 21% | +214.1K | $84.9M | 0.46% |
Cidara Therapeutics Incno ticker on file | ▼ Sold out | −382.8K | $84.6M | 0.46% |
| Tango Therapeutics IncTNGX | ▼ Reduced 30% | −3.96M | $82.9M | 0.45% |
| Kenvue IncKVUE | ▼ Reduced 11% | −4.74M | $81.7M | 0.45% |
| Vaxcyte IncPCVX | ▲ Added more than 10× | +1.26M | $73M | 0.40% |
| Dianthus Therapeutics IncDNTH | ▲ New | +836K | $70.2M | 0.38% |
| Hims & Hers Health IncHIMS | ▼ Reduced 100% | −3.38M | $70.1M | 0.38% |
| Brightspring Health Services IncBTSG | ▲ Added more than 10× | +1.6M | $68M | 0.37% |
| Twist Bioscience CorpTWST | ▲ Added more than 10× | +1.42M | $67.5M | 0.37% |
| UnitedHealth Group IncUNH | ▲ Added 14% | +222.8K | $60.3M | 0.33% |
| Alphabet IncGOOG | ▲ Added 27% | +209.19K | $60M | 0.33% |
| Amazon.com IncAMZN | ▼ Reduced 6.3% | −281.5K | $58.6M | 0.32% |
| Tyra Biosciences IncTYRA | ▲ Added 73% | +1.51M | $58M | 0.32% |
| The Charles Schwab CorpSCHW | ▲ Added 18% | +616K | $57.9M | 0.32% |
| TransUnionTRU | ▼ Sold out | −675K | $57.9M | 0.32% |
| Mckesson CorpMCK | ▼ Reduced 22% | −64.6K | $55.9M | 0.31% |
Crinetics Pharmaceuticalsno ticker on file | ▲ Added 20% | +1.41M | $51M | 0.28% |
| Aon PLCAON | ▼ Reduced 5.7% | −152.6K | $49.3M | 0.27% |
| Microsoft CorpMSFT | ▲ Added 5.9% | +130.7K | $48.4M | 0.26% |
| Vnet Group IncVNET | ▼ Reduced 90% | −5.66M | $47.5M | 0.26% |
| Grail IncGRAL | ▲ Added 39% | +911K | $47.1M | 0.26% |
| CG Oncology IncCGON | ▲ Added more than 10× | +666K | $45.1M | 0.25% |
| AstraZeneca PLCAZN | ▲ New | +226.5K | $44.7M | 0.24% |
Vnet Group Incno ticker on file | ▲ New | — | $44.5M | 0.24% |
| Cardinal Health IncCAH | ▼ Reduced 36% | −208K | $44M | 0.24% |
| Visa IncV | ▲ Added 21% | +144.8K | $43.8M | 0.24% |
| Merck & Co. IncMRK | ▲ New | +361K | $43.4M | 0.24% |
| Abivax SAABVX | ▼ Reduced 99% | −385K | $42.9M | 0.23% |
| Acadia Healthcare CompanyACHC | ▲ New | +1.74M | $40.6M | 0.22% |
| Immunovant IncIMVT | ▲ Added more than 10× | +1.53M | $38.1M | 0.21% |
| Johnson & JohnsonJNJ | ▲ New | +148K | $36.2M | 0.20% |
Terns Pharmaceuticals Incno ticker on file | ▼ Reduced 99% | −635K | $33.5M | 0.18% |
| iShares Ethereum Trust ETFETHA | ▼ Sold out | −1.48M | $33.2M | 0.18% |
Strategy Incno ticker on file | ▲ New | — | $32.9M | 0.18% |
| NetEase IncNTES | ▲ New | +291.22K | $32.6M | 0.18% |
| Structure Therapeutics IncGPCR | ▼ Sold out | −454K | $31.6M | 0.17% |
| Mineralys Therapeutics IncMLYS | ▼ Sold out | −823.3K | $29.9M | 0.16% |
Sunococorp LLCno ticker on file | ▼ Sold out | −606.28K | $29.9M | 0.16% |
| Novo Nordisk A/SNVO | ▲ New | +782K | $28.7M | 0.16% |
| Welltower IncWELL | ▼ Reduced 42% | −143K | $28.3M | 0.15% |
| Bridgebio Pharma IncBBIO | ▲ Added 4.1% | +367K | $27.3M | 0.15% |
| Royalty Pharma PLCRPRX | ▲ New | +493K | $23.6M | 0.13% |
Centessa Pharmaceuticals PLCno ticker on file | ▼ Reduced 11% | −568.07K | $22.6M | 0.12% |
| Encompass Health CorpEHC | ▼ Reduced 99% | −231.5K | $22.4M | 0.12% |
| Protagonist Therapeutics IncPTGX | ▲ Added 3.3% | +204.9K | $21.6M | 0.12% |
| Agios Pharmaceuticals IncAGIO | ▲ Added 10% | +524.5K | $17.7M | 0.10% |
| Amkor Technology IncAMKR | ▼ Reduced 78% | −360K | $16.2M | 0.09% |
| Verastem IncVSTM | ▼ Sold out | −2M | $15.4M | 0.08% |
| Tenet Healthcare CorpTHC | ▲ Added 22% | +80K | $15.1M | 0.08% |
| Baidu IncBIDU | ▲ Added 41% | +128.49K | $14.3M | 0.08% |
| Ceco Environmental CorpCECO | ▲ New | +234K | $13.9M | 0.08% |
| Doximity IncDOCS | ▼ Sold out | −311K | $13.8M | 0.08% |
| Avalo Therapeutics IncAVTX | ▲ New | +916K | $13.7M | 0.07% |
| Lantheus Holdings IncLNTH | ▲ Added 2.9% | +156K | $11.8M | 0.06% |
| GDS Holdings LtdGDS | ▲ New | +292K | $11.8M | 0.06% |
| Maze Therapeutics IncMAZE | ▲ New | +373K | $11.1M | 0.06% |
| Medline IncMDLN | ▼ Sold out | −260K | $10.9M | 0.06% |
| New Oriental ED & TechnologyEDU | ▼ Sold out | −196K | $10.8M | 0.06% |
| Teva Pharmaceutical IndustriesTEVA | ▲ Added 785% | +314K | $9.5M | 0.05% |
| Guardant Health IncGH | ▼ Reduced 93% | −101K | $9.3M | 0.05% |
| Beta Bionics IncBBNX | ▼ Reduced 16% | −706K | $7.1M | 0.04% |
| Grayscale Ethereum Mini TrustETH | ▼ Sold out | −228.34K | $6.4M | 0.04% |
| Formfactor IncFORM | ▲ New | +56.5K | $5.5M | 0.03% |
| Mastec IncMTZ | ▲ New | +17K | $5.5M | 0.03% |
| Entegris IncENTG | ▲ New | +45.5K | $5.3M | 0.03% |
| Citigroup IncC | ▲ New | +47K | $5.3M | 0.03% |
| Hyatt Hotels CorpH | ▲ New | +36K | $5.2M | 0.03% |
| Western Alliance BancorpWAL | ▲ New | +73K | $5.2M | 0.03% |
| Timken CoTKR | ▲ New | +51K | $5.1M | 0.03% |
| Flex LtdFLEX | ▲ New | +78K | $5.1M | 0.03% |
| S&P Global IncSPGI | ▲ New | +12K | $5.1M | 0.03% |
| Littelfuse IncLFUS | ▲ New | +15K | $5.1M | 0.03% |
| Piper Sandler CompaniesPIPR | ▲ New | +66K | $5.1M | 0.03% |
| Aar CorpAIR | ▲ New | +46K | $5M | 0.03% |
| Rio Tinto PLCRIO | ▲ New | +53.8K | $5M | 0.03% |
| Garrett Motion IncGTX | ▲ New | +275K | $5M | 0.03% |
| Rollins IncROL | ▲ New | +93K | $5M | 0.03% |
| Affirm Holdings IncAFRM | ▲ New | +108K | $4.9M | 0.03% |
| Inter & Co IncINTR | ▲ New | +614.5K | $4.9M | 0.03% |
| Cummins IncCMI | ▲ New | +9K | $4.8M | 0.03% |
| Fiserv IncFISV | ▲ New | +86K | $4.8M | 0.03% |
| Vertiv Holdings CoVRT | ▲ New | +19K | $4.8M | 0.03% |
| Atrium Therapeutics IncRNA | ▲ New | +349.36K | $4.7M | 0.03% |
| Globalfoundries IncGFS | ▲ New | +105K | $4.7M | 0.03% |
| Molina Healthcare IncMOH | ▲ New | +35K | $4.7M | 0.03% |
| Opus Genetics IncIRD | ▲ New | +1M | $4.6M | 0.02% |
| Tenable Holdings IncTENB | ▲ New | +265K | $4.5M | 0.02% |
| ServiceNow IncNOW | ▲ New | +41K | $4.3M | 0.02% |
| GeneDx Holdings CorpWGS | ▼ Reduced 93% | −65K | $4.2M | 0.02% |
| Boston Scientific CorpBSX | ▲ Added 0.4% | +31.12K | $2M | 0.01% |
| Beam Therapeutics IncBEAM | ▲ Added 0.7% | +71.59K | $1.7M | 0.01% |
| Enanta Pharmaceuticals IncENTA | ▲ Added 3.6% | +99.6K | $1.3M | 0.01% |
| Schrodinger IncSDGR | ▼ Reduced 76% | −54K | $613.4K | 0.00% |
| Insmed IncINSM | ▼ Sold out | −3K | $522.1K | 0.00% |
| Ascendis Pharma A/SASND | ▼ Sold out | −1.4K | $298.5K | 0.00% |
| Erasca IncERAS | ▲ New | +18K | $291.2K | 0.00% |
| Nektar TherapeuticsNKTR | ▲ New | +4K | $287.8K | 0.00% |
Arcellx Incno ticker on file | ▼ Sold out | −4K | $260.8K | 0.00% |
| Krystal Biotech IncKRYS | ▼ Reduced 50% | −1K | $258.3K | 0.00% |
| Alumis IncALMS | ▲ New | +11K | $242.3K | 0.00% |
Apellis Pharmaceuticals Incno ticker on file | ▲ New | +6K | $241.4K | 0.00% |
Soleno Therapeutics Incno ticker on file | ▼ Sold out | −5K | $231.5K | 0.00% |
| Icon Pub Ltd CoICLR | ▼ Sold out | −1.2K | $218.7K | 0.00% |
| Establishment Labs Holdings IncESTA | ▼ Sold out | −3K | $218.6K | 0.00% |
| Belite Bio IncBLTE | ▲ New | +1.3K | $207.3K | 0.00% |
Supernus Pharmaceuticals Incno ticker on file | ▲ New | +4K | $206.8K | 0.00% |
| Vir Biotechnology IncVIR | ▲ New | +22K | $197.1K | 0.00% |
| Healthequity IncHQY | ▼ Reduced 44% | −2.2K | $183.9K | 0.00% |
The filing as a whole has 48 new, 31 added, 30 reduced and 26 sold-out positions; listed are the moves among its 150 largest positions and 26 largest exits.
Holdings at the quarter's end
| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Held | Since Q4 2025 |
|---|---|---|---|---|---|---|---|---|
| 1 | Electronic Arts Incno ticker on file | — | 8.34% | $1.5B | 7.47M | $203.87 | 2 qtrs | ▲ Added 48% |
| 2 | Revolution Medicines IncRVMD | Health Care | 7.24% | $1.3B | 13.6M | $97.25 | 7+ qtrs | ▼ Reduced 6.7% |
| 3 | Amazon.com IncAMZN | Consumer Discretionary | 4.81% | $878.6M | 4.22M | $208.27 | 4 qtrs | ▼ Reduced 6.3% |
| 4 | Microsoft CorpMSFT | Technology | 4.75% | $868M | 2.34M | $370.17 | 7+ qtrs | ▲ Added 5.9% |
| 5 | Aon PLCAON · SHS CL A | Financials | 4.44% | $811M | 2.51M | $322.78 | 7+ qtrs | ▼ Reduced 5.7% |
| 6 | Warner Bros Discovery Incno ticker on file | — | 4.19% | $765.9M | 27.89M | $27.46 | 2 qtrs | ▲ Added 141% |
| 7 | Bridgebio Pharma IncBBIO | Health Care | 3.81% | $695.5M | 9.37M | $74.26 | 7+ qtrs | ▲ Added 4.1% |
| 8 | Protagonist Therapeutics IncPTGX | Health Care | 3.66% | $669.2M | 6.35M | $105.40 | 7+ qtrs | ▲ Added 3.3% |
| 9 | Natera IncNTRA | Health Care | 3.51% | $641.4M | 3.21M | $199.99 | 7+ qtrs | ▼ Reduced 18% |
| 10 | Kenvue IncKVUE | — | 3.47% | $633.3M | 36.74M | $17.24 | 2 qtrs | ▼ Reduced 11% |
| 11 | Exelixis IncEXEL | Health Care | 3.08% | $562.3M | 13.11M | $42.89 | 7+ qtrs | ▼ Reduced 17% |
| 12 | Broadcom IncAVGO | Technology | 3.02% | $550.8M | 1.78M | $309.51 | 2 qtrs | ▲ Added 99% |
| 13 | UnitedHealth Group IncUNH | Health Care | 2.70% | $492.9M | 1.82M | $270.59 | 7+ qtrs | ▲ Added 14% |
| 14 | Synopsys IncSNPS | Technology | 2.63% | $481M | 1.21M | $396.48 | 2 qtrs | ▲ Added 21% |
| 15 | Boston Scientific CorpBSX | Health Care | 2.57% | $468.8M | 7.47M | $62.75 | 7+ qtrs | ▲ Added 0.4% |
| 16 | Thermo Fisher Scientific IncTMO | Health Care | 2.37% | $433.3M | 881.49K | $491.53 | 7+ qtrs | ▲ Added 39% |
| 17 | KKR & Co. IncKKR | Financials | 2.37% | $432.1M | 4.67M | $92.50 | 2 qtrs | ▲ Added 132% |
| 18 | Lantheus Holdings IncLNTH | Health Care | 2.32% | $423.5M | 5.58M | $75.85 | 7+ qtrs | ▲ Added 2.9% |
| 19 | WabtecWAB | Industrials | 2.20% | $402.2M | 1.61M | $249.91 | 7+ qtrs | ▼ Reduced 35% |
| 20 | The Charles Schwab CorpSCHW | Financials | 2.04% | $371.8M | 3.96M | $93.98 | 6 qtrs | ▲ Added 18% |
| 21 | Liquidia CorporationLQDA | — | 1.79% | $326.7M | 8.66M | $37.74 | 7+ qtrs | No change |
| 22 | Crinetics Pharmaceuticalsno ticker on file | — | 1.66% | $302.8M | 8.34M | $36.32 | 7+ qtrs | ▲ Added 20% |
| 23 | Alphabet IncGOOG · CAP STK CL C | — | 1.57% | $285.8M | 996.23K | $286.86 | 7+ qtrs | ▲ Added 27% |
| 24 | Roivant Sciences LtdROIV · SHS | Health Care | 1.47% | $268M | 9.68M | $27.70 | 7+ qtrs | ▲ Added more than 10× |
| 25 | Visa IncV | Financials | 1.39% | $254.1M | 840.71K | $302.24 | 7+ qtrs | ▲ Added 21% |
| 26 | AramarkARMK | Consumer Discretionary | 1.36% | $248.7M | 6.14M | $40.54 | 7+ qtrs | ▼ Reduced 34% |
| 27 | Beam Therapeutics IncBEAM | — | 1.32% | $241.5M | 10.13M | $23.83 | 7+ qtrs | ▲ Added 0.7% |
| 28 | The Walt Disney CoDIS | Communication | 1.27% | $231.5M | 2.4M | $96.38 | 7+ qtrs | ▼ Reduced 42% |
| 29 | Mastercard IncMA · CL A | Financials | 1.19% | $217.4M | 435.07K | $499.66 | 7+ qtrs | ▲ Added 152% |
| 30 | Mckesson CorpMCK | Health Care | 1.11% | $202.8M | 234.3K | $865.36 | 6 qtrs | ▼ Reduced 22% |
| 31 | Agios Pharmaceuticals IncAGIO | — | 1.05% | $192.3M | 5.68M | $33.83 | 7+ qtrs | ▲ Added 10% |
| 32 | Centessa Pharmaceuticals PLCno ticker on file · SPONSORED ADS | — | 1.05% | $191M | 4.81M | $39.72 | 7+ qtrs | ▼ Reduced 11% |
| 33 | Tango Therapeutics IncTNGX | — | 1.04% | $190.3M | 9.1M | $20.92 | 6 qtrs | ▼ Reduced 30% |
| 34 | Grail IncGRAL | Health Care | 0.92% | $168.2M | 3.25M | $51.68 | 4 qtrs | ▲ Added 39% |
| 35 | Tyra Biosciences IncTYRA | — | 0.75% | $137.1M | 3.58M | $38.30 | 6 qtrs | ▲ Added 73% |
| 36 | Tenet Healthcare CorpTHC | Health Care | 0.47% | $85.3M | 452.15K | $188.71 | 4 qtrs | ▲ Added 22% |
| 37 | Cardinal Health IncCAH | Health Care | 0.43% | $77.8M | 368K | $211.31 | 5 qtrs | ▼ Reduced 36% |
| 38 | Vaxcyte IncPCVX | Health Care | 0.40% | $73.3M | 1.26M | $58.11 | 2 qtrs | ▲ Added more than 10× |
| 39 | Dianthus Therapeutics IncDNTH | Health Care | 0.38% | $70.2M | 836K | $83.92 | 1 qtr | New |
| 40 | Brightspring Health Services IncBTSG | Health Care | 0.38% | $68.9M | 1.62M | $42.61 | 7+ qtrs | ▲ Added more than 10× |
| 41 | Twist Bioscience CorpTWST | Health Care | 0.37% | $67.8M | 1.43M | $47.52 | 7+ qtrs | ▲ Added more than 10× |
| 42 | Baidu IncBIDU · SPON ADR REP A | Technology | 0.27% | $49.4M | 443.79K | $111.42 | 3 qtrs | ▲ Added 41% |
| 43 | CG Oncology IncCGON | Health Care | 0.25% | $45.6M | 674K | $67.68 | 4 qtrs | ▲ Added more than 10× |
| 44 | AstraZeneca PLCAZN · ORD | Health Care | 0.25% | $44.7M | 226.5K | $197.22 | 1 qtr | New |
| 45 | Vnet Group Incno ticker on file · NOTE 2.000%10/0 | — | 0.24% | $44.5M | — | — | 1 qtr | New |
| 46 | Merck & Co. IncMRK | Health Care | 0.24% | $43.4M | 361K | $120.29 | 1 qtr | New |
| 47 | Acadia Healthcare CompanyACHC | — | 0.22% | $40.6M | 1.74M | $23.39 | 1 qtr | New |
| 48 | Welltower IncWELL | Real Estate | 0.22% | $39.5M | 200K | $197.71 | 2 qtrs | ▼ Reduced 42% |
| 49 | Immunovant IncIMVT | Health Care | 0.21% | $38.4M | 1.55M | $24.84 | 7+ qtrs | ▲ Added more than 10× |
| 50 | Enanta Pharmaceuticals IncENTA | — | 0.20% | $36.3M | 2.87M | $12.63 | 7+ qtrs | ▲ Added 3.6% |
| 51 | Johnson & JohnsonJNJ | Health Care | 0.20% | $36.2M | 148K | $244.44 | 1 qtr | New |
| 52 | Beta Bionics IncBBNX | — | 0.20% | $36.2M | 3.61M | $10.02 | 5 qtrs | ▼ Reduced 16% |
| 53 | Assembly Biosciences IncASMB | — | 0.19% | $34.1M | 1.23M | $27.75 | 3 qtrs | No change |
| 54 | JOYY IncJOYY · ADS REPSTG COM A | — | 0.19% | $33.8M | 578.2K | $58.39 | 5 qtrs | No change |
| 55 | Strategy Incno ticker on file · NOTE 12/0 | — | 0.18% | $32.9M | — | — | 1 qtr | New |
| 56 | NetEase IncNTES · SPONSORED ADS | Technology | 0.18% | $32.6M | 291.22K | $111.94 | 1 qtr | New |
| 57 | Novo Nordisk A/SNVO · ADR | Health Care | 0.16% | $28.7M | 782K | $36.75 | 1 qtr | New |
| 58 | Bitwise 10 Crypto Index ETFBITW · UNIT BENEFICIAL | — | 0.15% | $26.9M | 603K | $44.61 | 2 qtrs | ▼ Reduced 82% |
| 59 | Perceptive Cap Solutionsno ticker on file · CL A ORD SHS | — | 0.14% | $24.7M | 2.25M | $10.97 | 2 qtrs | No change |
| 60 | Royalty Pharma PLCRPRX · SHS CLASS A | Health Care | 0.13% | $23.6M | 493K | $47.97 | 1 qtr | New |
| 61 | Minerva Neurosciences IncNERV | — | 0.08% | $14.2M | 2.37M | $6.03 | 2 qtrs | No change |
| 62 | Ceco Environmental CorpCECO | — | 0.08% | $13.9M | 234K | $59.58 | 1 qtr | New |
| 63 | Avalo Therapeutics IncAVTX | — | 0.08% | $13.7M | 916K | $14.93 | 1 qtr | New |
| 64 | GDS Holdings LtdGDS · SPONSORED ADS | — | 0.06% | $11.8M | 292K | $40.29 | 1 qtr | New |
| 65 | Maze Therapeutics IncMAZE | — | 0.06% | $11.1M | 373K | $29.85 | 1 qtr | New |
| 66 | Teva Pharmaceutical IndustriesTEVA · SPONSORED ADS | Health Care | 0.06% | $10.7M | 354K | $30.12 | 3 qtrs | ▲ Added 785% |
| 67 | Formfactor IncFORM | Technology | 0.03% | $5.5M | 56.5K | $96.99 | 1 qtr | New |
| 68 | Mastec IncMTZ | Industrials | 0.03% | $5.5M | 17K | $321.74 | 1 qtr | New |
| 69 | Entegris IncENTG | Materials | 0.03% | $5.3M | 45.5K | $117.24 | 1 qtr | New |
| 70 | Citigroup IncC | Financials | 0.03% | $5.3M | 47K | $113.41 | 1 qtr | New |
| 71 | Vnet Group IncVNET · SPONSORED ADS A | — | 0.03% | $5.2M | 623.35K | $8.39 | 7+ qtrs | ▼ Reduced 90% |
| 72 | Hyatt Hotels CorpH | Consumer Discretionary | 0.03% | $5.2M | 36K | $143.79 | 1 qtr | New |
| 73 | Western Alliance BancorpWAL | Financials | 0.03% | $5.2M | 73K | $70.85 | 1 qtr | New |
| 74 | Timken CoTKR | Industrials | 0.03% | $5.1M | 51K | $100.57 | 1 qtr | New |
| 75 | Flex LtdFLEX · ORD | Technology | 0.03% | $5.1M | 78K | $65.46 | 1 qtr | New |
| 76 | S&P Global IncSPGI | Financials | 0.03% | $5.1M | 12K | $425.34 | 1 qtr | New |
| 77 | Littelfuse IncLFUS | Industrials | 0.03% | $5.1M | 15K | $339.35 | 1 qtr | New |
| 78 | Piper Sandler CompaniesPIPR | Financials | 0.03% | $5.1M | 66K | $76.55 | 1 qtr | New |
| 79 | Aar CorpAIR | Industrials | 0.03% | $5M | 46K | $109.46 | 1 qtr | New |
| 80 | Rio Tinto PLCRIO · SPONSORED ADR | Materials | 0.03% | $5M | 53.8K | $93.29 | 1 qtr | New |
| 81 | Garrett Motion IncGTX | — | 0.03% | $5M | 275K | $18.17 | 1 qtr | New |
| 82 | Rollins IncROL | Industrials | 0.03% | $5M | 93K | $53.41 | 1 qtr | New |
| 83 | Affirm Holdings IncAFRM | Financials | 0.03% | $4.9M | 108K | $45.82 | 1 qtr | New |
| 84 | Inter & Co IncINTR · CLASS A COM | — | 0.03% | $4.9M | 614.5K | $7.96 | 1 qtr | New |
| 85 | Cummins IncCMI | Industrials | 0.03% | $4.8M | 9K | $538.02 | 1 qtr | New |
| 86 | Fiserv IncFISV | Financials | 0.03% | $4.8M | 86K | $55.80 | 1 qtr | New |
| 87 | Vertiv Holdings CoVRT | Technology | 0.03% | $4.8M | 19K | $250.58 | 1 qtr | New |
| 88 | Amkor Technology IncAMKR | Technology | 0.03% | $4.7M | 104K | $45.03 | 2 qtrs | ▼ Reduced 78% |
| 89 | Atrium Therapeutics IncRNA | — | 0.03% | $4.7M | 349.36K | $13.37 | 1 qtr | New |
| 90 | Globalfoundries IncGFS · ORDINARY SHARES | Technology | 0.03% | $4.7M | 105K | $44.48 | 1 qtr | New |
| 91 | Molina Healthcare IncMOH | Health Care | 0.03% | $4.7M | 35K | $133.30 | 1 qtr | New |
| 92 | Opus Genetics IncIRD | — | 0.03% | $4.6M | 1M | $4.55 | 1 qtr | New |
| 93 | Tenable Holdings IncTENB | — | 0.03% | $4.5M | 265K | $16.92 | 1 qtr | New |
| 94 | Prime Medicine IncPRME | — | 0.02% | $4.3M | 1.24M | $3.48 | 7+ qtrs | No change |
| 95 | ServiceNow IncNOW | Technology | 0.02% | $4.3M | 41K | $104.55 | 1 qtr | New |
| 96 | Summit Midstream CorporationSMC | — | 0.01% | $1.8M | 58.21K | $30.24 | 7+ qtrs | No change |
| 97 | Madrigal Pharmaceuticals IncMDGL | Health Care | 0.01% | $1.7M | 3.32K | $523.47 | 7+ qtrs | No change |
| 98 | Capricor Therapeutics IncCAPR | — | 0.01% | $1.2M | 41K | $30.40 | 6 qtrs | No change |
| 99 | Arrowhead PharmaceuticalsARWR | Health Care | 0.01% | $990.7K | 15.8K | $62.70 | 6 qtrs | No change |
| 100 | Aleanna Incno ticker on file · *W EXP 12/13/202 | — | 0.00% | $801.9K | 990K | $0.8100 | 6 qtrs | No change |
| 101 | Guardant Health IncGH | Health Care | 0.00% | $739K | 8K | $92.37 | 4 qtrs | ▼ Reduced 93% |
| 102 | Alkermes PLCALKS · SHS | Health Care | 0.00% | $735.5K | 20.8K | $35.36 | 5 qtrs | No change |
| 103 | Alvotech SAALVO · ORDINARY SHARES | — | 0.00% | $684.9K | 199.68K | $3.43 | 7+ qtrs | No change |
| 104 | Axsome Therapeutics IncAXSM | Health Care | 0.00% | $676.1K | 4K | $169.02 | 7+ qtrs | No change |
| 105 | Cogent Biosciences IncCOGT | Health Care | 0.00% | $654.3K | 17K | $38.49 | 7+ qtrs | No change |
| 106 | Aleanna Incno ticker on file | — | 0.00% | $649.9K | 78.4K | $8.29 | 6 qtrs | No change |
| 107 | Arcutis Biotherapeutics IncARQT | — | 0.00% | $612.6K | 26K | $23.56 | 7+ qtrs | No change |
| 108 | Celcuity IncCELC | — | 0.00% | $456.6K | 4K | $114.14 | 2 qtrs | No change |
| 109 | Livanova PLCLIVN · SHS | Health Care | 0.00% | $381.4K | 6K | $63.56 | 5 qtrs | No change |
| 110 | Terns Pharmaceuticals Incno ticker on file | — | 0.00% | $369K | 7K | $52.72 | 2 qtrs | ▼ Reduced 99% |
| 111 | Ionis Pharmaceuticals IncIONS | Health Care | 0.00% | $360.4K | 4.8K | $75.09 | 3 qtrs | No change |
| 112 | Travere Therapeutics IncTVTX | Health Care | 0.00% | $356.5K | 12K | $29.71 | 4 qtrs | No change |
| 113 | Globus Med IncGMED · CL A | Health Care | 0.00% | $344.6K | 4K | $86.16 | 7+ qtrs | No change |
| 114 | Scholar Rock Holding CorpSRRK | Health Care | 0.00% | $344.1K | 7K | $49.16 | 6 qtrs | No change |
| 115 | Beone Medicines LtdONC · SPONSORED ADS | Health Care | 0.00% | $326.7K | 1.1K | $296.97 | 7+ qtrs | No change |
| 116 | GeneDx Holdings CorpWGS | — | 0.00% | $321.1K | 5K | $64.22 | 6 qtrs | ▼ Reduced 93% |
| 117 | Cencora IncCOR | Health Care | 0.00% | $314.1K | 1K | $314.14 | 7+ qtrs | No change |
| 118 | Nuvalent Incno ticker on file | — | 0.00% | $307.4K | 3K | $102.45 | 7+ qtrs | No change |
| 119 | Progyny IncPGNY | — | 0.00% | $305.6K | 18K | $16.98 | 7+ qtrs | No change |
| 120 | Stoke Therapeutics IncSTOK | — | 0.00% | $293K | 9K | $32.56 | 2 qtrs | No change |
| 121 | Erasca IncERAS | Health Care | 0.00% | $291.2K | 18K | $16.18 | 1 qtr | New |
| 122 | Encompass Health CorpEHC | Health Care | 0.00% | $290.2K | 3K | $96.73 | 7+ qtrs | ▼ Reduced 99% |
| 123 | Nektar TherapeuticsNKTR | — | 0.00% | $287.8K | 4K | $71.95 | 1 qtr | New |
| 124 | Glaukos CorpGKOS | Health Care | 0.00% | $279.9K | 2.6K | $107.66 | 7+ qtrs | No change |
| 125 | Mirum Pharmaceuticals IncMIRM | Health Care | 0.00% | $277.1K | 3K | $92.38 | 3 qtrs | No change |
| 126 | Sabra Health Care REIT IncSBRA | Real Estate | 0.00% | $269.2K | 14K | $19.23 | 7+ qtrs | No change |
| 127 | Krystal Biotech IncKRYS | Health Care | 0.00% | $258.3K | 1K | $258.32 | 7+ qtrs | ▼ Reduced 50% |
| 128 | Omeros CorpOMER | — | 0.00% | $242.9K | 23K | $10.56 | 2 qtrs | No change |
| 129 | Alumis IncALMS | — | 0.00% | $242.3K | 11K | $22.03 | 1 qtr | New |
| 130 | Apellis Pharmaceuticals Incno ticker on file | — | 0.00% | $241.4K | 6K | $40.23 | 1 qtr | New |
| 131 | Healthequity IncHQY | Health Care | 0.00% | $234K | 2.8K | $83.57 | 7+ qtrs | ▼ Reduced 44% |
| 132 | Syndax Pharmaceuticals IncSNDX | — | 0.00% | $233.6K | 10K | $23.36 | 7+ qtrs | No change |
| 133 | Amicus Therapeuticno ticker on file | — | 0.00% | $231.4K | 16K | $14.46 | 7+ qtrs | No change |
| 134 | Uniqure NVQURE · SHS | — | 0.00% | $228.9K | 14K | $16.35 | 5 qtrs | No change |
| 135 | BioCryst Pharmaceuticals IncBCRX | — | 0.00% | $228.5K | 24K | $9.52 | 3 qtrs | No change |
| 136 | Veracyte IncVCYT | — | 0.00% | $225.5K | 7K | $32.21 | 3 qtrs | No change |
| 137 | Grifols S AGRFS · SP ADR REP B NVT | Health Care | 0.00% | $224.6K | 28K | $8.02 | 7+ qtrs | No change |
| 138 | Abivax SAABVX · SPONSORED ADS | Health Care | 0.00% | $222.7K | 2K | $111.35 | 3 qtrs | ▼ Reduced 99% |
| 139 | GE HealthCare Technologies IncGEHC | Health Care | 0.00% | $213.5K | 3K | $71.18 | 6 qtrs | No change |
| 140 | Revolution Medicines Incno ticker on file · *W EXP 12/17/202 | — | 0.00% | $208.9K | 120.09K | $1.74 | 7+ qtrs | No change |
| 141 | Hims & Hers Health IncHIMS | Health Care | 0.00% | $207.6K | 10K | $20.76 | 7+ qtrs | ▼ Reduced 100% |
| 142 | Belite Bio IncBLTE · SPONSORED ADS | Health Care | 0.00% | $207.3K | 1.3K | $159.44 | 1 qtr | New |
| 143 | Merit Med Systems IncMMSI | Health Care | 0.00% | $206.8K | 3K | $68.93 | 7+ qtrs | No change |
| 144 | Supernus Pharmaceuticals Incno ticker on file | — | 0.00% | $206.8K | 4K | $51.69 | 1 qtr | New |
| 145 | Healthcare Realty TrustHR · CL A COM | Real Estate | 0.00% | $203.9K | 12K | $16.99 | 7+ qtrs | No change |
| 146 | UroGen Pharma LtdURGN | — | 0.00% | $197.8K | 11K | $17.98 | 3 qtrs | No change |
| 147 | Vir Biotechnology IncVIR | — | 0.00% | $197.1K | 22K | $8.96 | 1 qtr | New |
| 148 | Precigen IncPGEN | — | 0.00% | $193.5K | 50K | $3.87 | 2 qtrs | No change |
| 149 | Schrodinger IncSDGR | — | 0.00% | $193.1K | 17K | $11.36 | 4 qtrs | ▼ Reduced 76% |
| 150 | Dyne Therapeutics IncDYN | — | 0.00% | $181.3K | 10K | $18.13 | 7+ qtrs | No change |
Showing the 150 largest of 172 positions.
By sector
| Sector | Share of portfolio | Value | Positions |
|---|---|---|---|
| Health Care | 38.8% | $7.1B | 52 |
| Financials | 11.6% | $2.1B | 11 |
| Technology | 11.0% | $2B | 11 |
| Consumer Discretionary | 6.20% | $1.1B | 3 |
| Industrials | 2.37% | $432.7M | 7 |
| Communication | 1.27% | $231.5M | 1 |
| Real Estate | 0.22% | $40M | 3 |
| Materials | 0.06% | $10.4M | 2 |
| No sector on file | 28.5% | $5.2B | 60 |
| Beyond the 150 largest positions | 0.01% | — | — |
Questions and answers
What did Andrew Spokes own in Q1 2026?
Farallon Capital Management's 13F for Q1 2026 lists 172 positions worth $18.3B. The largest: Electronic Arts Inc (8.3%), RVMD (7.2%), AMZN (4.8%), MSFT (4.8%), AON (4.4%).
What did Andrew Spokes buy in Q1 2026?
The largest purchases, by the shares bought at the quarter-end price the filing implies: Electronic Arts Inc (added, $496.4M), Warner Bros Discovery Inc (added, $448.1M), AVGO (added, $274.6M), ROIV (added, $267M), KKR (added, $245.5M), MA (added, $131.1M).
What did Andrew Spokes sell in Q1 2026?
The largest sales: Exact Sciences Corp (sold out, $650.5M), CyberArk Software Ltd (sold out, $469.7M), CRM (sold out, $334.1M), NDAQ (sold out, $290.3M), Avidity Biosciences Inc (sold out, $233.2M), NYT (sold out, $227.7M).
When was this filing made?
Farallon Capital Management filed its 13F for the quarter ending Mar 31, 2026 on May 15, 2026, and amended it on Nov 16, 2026; the figures here include the amendment. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.
Learn
Cite this page
Funkfolio, “Andrew Spokes portfolio, Q1 2026: Farallon Capital Management 13F holdings”, data as of 16 November 2026. https://funkfolio.com/gurus/farallon/2026-q1
Underlying data: SEC EDGAR, Form 13F-HR of Farallon Capital Management (CIK 909661) for the period ending Mar 31, 2026.
Source: SEC EDGAR, Form 13F-HR for Farallon Capital Management (CIK 909661), period ending Mar 31, 2026, filed May 15, 2026, amended Nov 16, 2026. Changes compare share counts with the filing for Dec 31, 2025; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $18.3B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 7 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. 3 option positions in the filing are not shown. Not a live portfolio and not advice.